| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mRNA 5'-UTR binding | 3.16e-04 | 25 | 107 | 3 | GO:0048027 | |
| GeneOntologyMolecularFunction | phosphatidylcholine flippase activity | 4.21e-04 | 6 | 107 | 2 | GO:0140345 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 4.45e-04 | 28 | 107 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | structural constituent of ribosome | 4.59e-04 | 183 | 107 | 6 | GO:0003735 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA2 ABCA3 RNGTT SMCHD1 SMC1A DNAH2 GBP2 RGS9 ARHGAP35 NKIRAS1 ATP8B2 NLRP10 HSPA2 | 5.47e-04 | 839 | 107 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA2 ABCA3 RNGTT SMCHD1 SMC1A DNAH2 GBP2 RGS9 ARHGAP35 NKIRAS1 ATP8B2 NLRP10 HSPA2 | 5.54e-04 | 840 | 107 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA2 ABCA3 RNGTT SMCHD1 SMC1A DNAH2 GBP2 RGS9 ARHGAP35 NKIRAS1 ATP8B2 NLRP10 HSPA2 | 5.54e-04 | 840 | 107 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | GTPase activator activity | 7.65e-04 | 279 | 107 | 7 | GO:0005096 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA2 ABCA3 SMCHD1 SMC1A DNAH2 GBP2 RGS9 ARHGAP35 NKIRAS1 ATP8B2 NLRP10 HSPA2 | 9.09e-04 | 775 | 107 | 12 | GO:0017111 |
| GeneOntologyBiologicalProcess | positive regulation of ATPase-coupled calcium transmembrane transporter activity | 2.54e-06 | 6 | 105 | 3 | GO:1901896 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | DOCK1 ABCA2 ABCA3 CKAP5 GBP2 CLASP2 ARHGAP35 ASAP1 CEP120 SUMO1 PRKCE CGNL1 C9orf72 RPL13A IL1RAP HSPA2 HCFC1 EPHA7 | 2.93e-05 | 1189 | 105 | 18 | GO:0044087 |
| GeneOntologyBiologicalProcess | regulation of ATPase-coupled calcium transmembrane transporter activity | 3.53e-05 | 13 | 105 | 3 | GO:1901894 | |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 5.55e-05 | 41 | 105 | 4 | GO:0070286 | |
| GeneOntologyBiologicalProcess | cilium assembly | DNAH2 DNAAF11 ARHGAP35 CFAP298 NME8 ASAP1 CEP120 DNAH17 CFAP74 CFAP57 | 9.00e-05 | 444 | 105 | 10 | GO:0060271 |
| GeneOntologyCellularComponent | sperm flagellum | 1.17e-04 | 214 | 107 | 7 | GO:0036126 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 2.25e-04 | 238 | 107 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | cytosolic large ribosomal subunit | 2.38e-04 | 59 | 107 | 4 | GO:0022625 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.76e-04 | 25 | 107 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | large ribosomal subunit | 3.54e-04 | 118 | 107 | 5 | GO:0015934 | |
| GeneOntologyCellularComponent | cytosolic ribosome | 4.44e-04 | 124 | 107 | 5 | GO:0022626 | |
| GeneOntologyCellularComponent | motile cilium | 4.84e-04 | 355 | 107 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | ribosomal subunit | 4.91e-04 | 194 | 107 | 6 | GO:0044391 | |
| GeneOntologyCellularComponent | cytoplasmic region | 5.31e-04 | 360 | 107 | 8 | GO:0099568 | |
| GeneOntologyCellularComponent | axoneme | 6.91e-04 | 207 | 107 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 7.09e-04 | 208 | 107 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.23e-03 | 317 | 107 | 7 | GO:0032838 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.58e-03 | 45 | 107 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | outer dynein arm | 1.66e-03 | 12 | 107 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | presynaptic cytosol | 2.02e-03 | 49 | 107 | 3 | GO:0099523 | |
| HumanPheno | Atelectasis | 3.11e-05 | 80 | 40 | 6 | HP:0100750 | |
| HumanPheno | Ciliary dyskinesia | 1.00e-04 | 32 | 40 | 4 | HP:0012265 | |
| HumanPheno | Abnormal ciliary motility | 1.28e-04 | 34 | 40 | 4 | HP:0012262 | |
| HumanPheno | Polysplenia | 1.45e-04 | 66 | 40 | 5 | HP:0001748 | |
| HumanPheno | Abnormal respiratory motile cilium physiology | 1.60e-04 | 36 | 40 | 4 | HP:0012261 | |
| HumanPheno | Recurrent upper and lower respiratory tract infections | 1.67e-04 | 68 | 40 | 5 | HP:0002873 | |
| HumanPheno | Recurrent sinopulmonary infections | 1.67e-04 | 68 | 40 | 5 | HP:0005425 | |
| HumanPheno | Productive cough | 1.67e-04 | 68 | 40 | 5 | HP:0031245 | |
| HumanPheno | Abnormal pulmonary thoracic imaging finding | 1.83e-04 | 157 | 40 | 7 | HP:0031983 | |
| HumanPheno | Absent outer dynein arms | 1.91e-04 | 15 | 40 | 3 | HP:0012256 | |
| HumanPheno | Abnormal pulmonary interstitial morphology | 2.14e-04 | 161 | 40 | 7 | HP:0006530 | |
| HumanPheno | Abnormal sperm motility | 2.38e-04 | 115 | 40 | 6 | HP:0012206 | |
| HumanPheno | Abnormal sperm physiology | 2.38e-04 | 115 | 40 | 6 | HP:0034809 | |
| HumanPheno | Interstitial pneumonitis | 2.83e-04 | 17 | 40 | 3 | HP:0006515 | |
| HumanPheno | Absent/shortened dynein arms | 2.83e-04 | 17 | 40 | 3 | HP:0200106 | |
| Domain | Ribosomal_L26 | 2.95e-05 | 2 | 102 | 2 | PF16906 | |
| Domain | Ribosomal_L26/L24P_euk/arc | 2.95e-05 | 2 | 102 | 2 | IPR005756 | |
| Domain | Ribosomal_L24/26_CS | 8.83e-05 | 3 | 102 | 2 | IPR005825 | |
| Domain | RIBOSOMAL_L24 | 8.83e-05 | 3 | 102 | 2 | PS01108 | |
| Domain | CLASP_N | 1.76e-04 | 4 | 102 | 2 | PF12348 | |
| Domain | CLASP_N_dom | 1.76e-04 | 4 | 102 | 2 | IPR024395 | |
| Domain | DOCK_N | 2.92e-04 | 5 | 102 | 2 | PF16172 | |
| Domain | DOCK_N | 2.92e-04 | 5 | 102 | 2 | IPR032376 | |
| Domain | SMC_hinge | 4.37e-04 | 6 | 102 | 2 | SM00968 | |
| Domain | SMC_hinge | 4.37e-04 | 6 | 102 | 2 | PF06470 | |
| Domain | SMC_hinge | 4.37e-04 | 6 | 102 | 2 | IPR010935 | |
| Domain | KOW | 6.09e-04 | 7 | 102 | 2 | SM00739 | |
| Domain | KOW | 1.57e-03 | 11 | 102 | 2 | IPR005824 | |
| Domain | KOW | 1.57e-03 | 11 | 102 | 2 | PF00467 | |
| Domain | DHR-1_domain | 1.57e-03 | 11 | 102 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.57e-03 | 11 | 102 | 2 | PS51651 | |
| Domain | DHR_1 | 1.57e-03 | 11 | 102 | 2 | PS51650 | |
| Domain | DHR-2 | 1.57e-03 | 11 | 102 | 2 | PF06920 | |
| Domain | DOCK | 1.57e-03 | 11 | 102 | 2 | IPR026791 | |
| Domain | DOCK_C | 1.57e-03 | 11 | 102 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 1.57e-03 | 11 | 102 | 2 | PF14429 | |
| Domain | DHR-2 | 1.57e-03 | 11 | 102 | 2 | IPR027357 | |
| Domain | ABC_A | 1.88e-03 | 12 | 102 | 2 | IPR026082 | |
| Domain | Translation_prot_SH3-like | 3.81e-03 | 17 | 102 | 2 | IPR008991 | |
| Domain | Rib_L2_dom2 | 4.27e-03 | 18 | 102 | 2 | IPR014722 | |
| Domain | - | 4.27e-03 | 18 | 102 | 2 | 2.30.30.30 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPL26 ESYT1 SMCHD1 SMC1A RPS13 SIN3A PAICS NKRF CD2 SUMO1 PHF3 UTP11 RPL26L1 SF3B6 SCAF11 RPL13A RPL4 HCFC1 FTSJ3 | 2.15e-10 | 989 | 108 | 19 | 36424410 |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 8.06e-09 | 256 | 108 | 10 | 32698014 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RPL26 MRPL12 SMCHD1 SMC1A RPS13 CKAP5 CLASP2 SIN3A ARHGAP35 MDH1 PAICS STAT3 GSR USO1 SF3B6 SCAF11 RPL13A RPL4 HCFC1 FTSJ3 | 1.31e-08 | 1415 | 108 | 20 | 28515276 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL26 RNGTT SMCHD1 SMC1A RPS13 CKAP5 SIN3A NKRF CRYZ KIN PHF3 SCAF11 RPL13A RPL4 FTSJ3 | 1.41e-08 | 759 | 108 | 15 | 35915203 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL26 DCAF8 MRPL12 SMC1A RPS13 CKAP5 CLASP2 MDH1 PAICS GSR LRRIQ1 USO1 RPL26L1 RPL13A HSPA2 RPL4 HCFC1 FTSJ3 | 1.62e-08 | 1149 | 108 | 18 | 35446349 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPL26 SMCHD1 SMC1A RPS13 CKAP5 SIN3A SKIL NKRF KMT2C SUMO1 PHF3 SCAF11 RPL13A MGA TET3 RPL4 HCFC1 MYBL2 FTSJ3 | 1.73e-08 | 1294 | 108 | 19 | 30804502 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RPL26 MRPL12 ESYT1 SMCHD1 CKAP5 SIN3A ARHGAP35 NKRF STAT3 GSR SUMO1 CGNL1 RPL13A RPL4 HCFC1 FTSJ3 | 3.27e-08 | 934 | 108 | 16 | 33916271 |
| Pubmed | 3.38e-08 | 222 | 108 | 9 | 37071664 | ||
| Pubmed | RPL26 ACADM DNAJC8 SMCHD1 RPS13 CLASP2 NKRF USO1 SUMO1 RPL26L1 SF3B6 RPL13A RPL4 FTSJ3 | 5.74e-08 | 723 | 108 | 14 | 34133714 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DNAJC8 ESYT1 SMCHD1 SMC1A RPS13 CKAP5 CLASP2 MDH1 PAICS POLR3A GSR USO1 SUMO1 RPL26L1 TLN2 RPL13A RPL4 HCFC1 FTSJ3 | 7.90e-08 | 1425 | 108 | 19 | 30948266 |
| Pubmed | RPL26 MRPL12 SMCHD1 SMC1A RPS13 ZNF521 SIN3A NKRF STAT3 KMT2C SUMO1 RPL26L1 NT5C2 SCAF11 RPL13A MGA HCFC1 MYBL2 FTSJ3 | 8.25e-08 | 1429 | 108 | 19 | 35140242 | |
| Pubmed | ACADM ESYT1 SMC1A RPS13 CKAP5 CLASP2 SIN3A PAICS NKRF STAT3 USO1 HSPA2 RPL4 | 9.87e-08 | 638 | 108 | 13 | 33239621 | |
| Pubmed | RPL26 ACADM UACA MRPL12 DNAJC8 SMC1A RPS13 PAICS NKRF ASAP2 RPL26L1 SF3B6 RPL13A HSPA2 RPL4 HCFC1 FTSJ3 | 1.01e-07 | 1153 | 108 | 17 | 29845934 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPM2 RPL26 DCAF8 ACADM DNAJC8 ACO1 SMC1A RPS13 GBP2 VPS26A PAICS STAT3 GSR CRYZ SUMO1 RPL26L1 NT5C2 KYNU HCFC1 | 1.09e-07 | 1455 | 108 | 19 | 22863883 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 2.53e-07 | 370 | 108 | 10 | 22922362 | |
| Pubmed | 3.02e-07 | 208 | 108 | 8 | 11790298 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.02e-07 | 208 | 108 | 8 | 33230847 | |
| Pubmed | DOCK1 DNAJC8 ESYT1 SMC1A RPS13 CKAP5 PAICS STAT3 USO1 ARHGAP12 RPL13A RPL4 HCFC1 | 3.23e-07 | 708 | 108 | 13 | 39231216 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RPL26 RNGTT ACADM ESYT1 SMC1A RPS13 PAICS NKRF POLR3A CDC7 RPL26L1 SF3B6 C9orf72 RPL13A HSPA2 RPL4 HCFC1 | 3.41e-07 | 1257 | 108 | 17 | 37317656 |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 4.78e-07 | 221 | 108 | 8 | 29991511 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | RNGTT MRPL12 DNAJC8 ESYT1 SMC1A RPS13 SAV1 CLASP2 DNAAF11 NME8 NKRF CDC7 STRN ASAP2 CEP120 RPL26L1 SF3B6 | 6.77e-07 | 1321 | 108 | 17 | 27173435 |
| Pubmed | MRPL12 DNAJC8 SMC1A KIN UTP11 RPL26L1 SF3B6 RPL13A RPL4 FTSJ3 | 7.84e-07 | 419 | 108 | 10 | 15635413 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 9.36e-07 | 329 | 108 | 9 | 34316702 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.01e-06 | 332 | 108 | 9 | 32786267 | |
| Pubmed | DNAJC8 SMCHD1 SIN3A ARHGAP35 PAICS NKRF STAT3 KMT2C PHF3 MGA HCFC1 | 1.19e-06 | 549 | 108 | 11 | 38280479 | |
| Pubmed | 1.22e-06 | 109 | 108 | 6 | 29511296 | ||
| Pubmed | 1.24e-06 | 441 | 108 | 10 | 31239290 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL26 UACA ESYT1 SMCHD1 SMC1A RPS13 CKAP5 PAICS NKRF KIN PHF3 UTP11 SCAF11 RPL13A RPL4 FTSJ3 | 1.72e-06 | 1257 | 108 | 16 | 36526897 |
| Pubmed | RPL26 MRPL12 SMC1A RPS13 PAICS NKRF PHF3 RPL26L1 SF3B6 SCAF11 RPL13A RPL4 FTSJ3 | 2.37e-06 | 847 | 108 | 13 | 35850772 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPM2 RPL26 MRPL12 DNAJC8 SMC1A RPS13 DNAH2 CKAP5 POLR3A TLN2 RPL13A HSPA2 RPL4 | 2.37e-06 | 847 | 108 | 13 | 35235311 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPM2 MYCN ESYT1 SMC1A CKAP5 SIN3A SKIL NKRF STAT3 USO1 MGA HCFC1 MYBL2 | 2.69e-06 | 857 | 108 | 13 | 25609649 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DCAF8 UACA MRPL12 DNAJC8 SMC1A CKAP5 CLASP2 STRN CEP120 KIN SUMO1 SF3B6 TLN2 HCFC1 MYBL2 | 2.94e-06 | 1155 | 108 | 15 | 20360068 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RPL26 GLRX5 ACADM ESYT1 SMCHD1 SMC1A RPS13 VPS26A PAICS NKRF STAT3 SF3B6 RPL13A RPL4 HCFC1 FTSJ3 | 3.16e-06 | 1318 | 108 | 16 | 30463901 |
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 3.32e-06 | 384 | 108 | 9 | 31059266 | |
| Pubmed | DOCK2 UACA SMC1A ARHGAP35 ATP8B2 ASAP2 DNAH17 ZNF518B CGNL1 MGA | 3.35e-06 | 493 | 108 | 10 | 15368895 | |
| Pubmed | DOCK2 RPL26 ABCA2 ESYT1 RPS13 CKAP5 CLASP2 PAICS POLR3A USO1 RPL13A IL1RAP HSPA2 RPL4 HCFC1 | 3.37e-06 | 1168 | 108 | 15 | 19946888 | |
| Pubmed | 3.41e-06 | 494 | 108 | 10 | 26831064 | ||
| Pubmed | 3.60e-06 | 497 | 108 | 10 | 23414517 | ||
| Pubmed | 4.53e-06 | 399 | 108 | 9 | 37536630 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | TPM2 RPL26 MRPL12 ACO1 ESYT1 CKAP5 SIN3A VPS26A MDH1 PAICS ASAP1 CRYZ USO1 SF3B6 RPL13A HCFC1 | 5.02e-06 | 1367 | 108 | 16 | 32687490 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 5.63e-06 | 410 | 108 | 9 | 26949251 | |
| Pubmed | RPL26 SMCHD1 CKAP5 PAICS NKRF PHF3 SCAF11 HSPA2 RPL4 HCFC1 FTSJ3 | 6.25e-06 | 653 | 108 | 11 | 22586326 | |
| Pubmed | FIP200 controls the TBK1 activation threshold at SQSTM1/p62-positive condensates. | 6.53e-06 | 223 | 108 | 7 | 34226595 | |
| Pubmed | 7.94e-06 | 87 | 108 | 5 | 15189156 | ||
| Pubmed | RPL26 UACA MRPL12 ESYT1 SMCHD1 SMC1A RPS13 CKAP5 PAICS NKRF RPL13A RPL4 | 8.38e-06 | 809 | 108 | 12 | 32129710 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | DNAJC8 SMCHD1 SMC1A NKRF SUMO1 PHF3 UTP11 SCAF11 MGA HSPA2 HCFC1 MYBL2 FTSJ3 | 8.55e-06 | 954 | 108 | 13 | 36373674 |
| Pubmed | 8.73e-06 | 327 | 108 | 8 | 34428256 | ||
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 8.73e-06 | 327 | 108 | 8 | 15592455 | |
| Pubmed | Interleukin-1beta activates a short STAT-3 isoform in clonal insulin-secreting cells. | 9.55e-06 | 2 | 108 | 2 | 9923604 | |
| Pubmed | Role of the HCF-1 basic region in sustaining cell proliferation. | 9.55e-06 | 2 | 108 | 2 | 20126307 | |
| Pubmed | Targeting Ras-Driven Cancer Cell Survival and Invasion through Selective Inhibition of DOCK1. | 9.55e-06 | 2 | 108 | 2 | 28467910 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 33106998 | ||
| Pubmed | Sav1 Loss Induces Senescence and Stat3 Activation Coinciding with Tubulointerstitial Fibrosis. | 9.55e-06 | 2 | 108 | 2 | 28320873 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21480396 | ||
| Pubmed | STAT3-EphA7 axis contributes to the progression of esophageal squamous cell carcinoma. | 9.55e-06 | 2 | 108 | 2 | 37738252 | |
| Pubmed | Addiction of MYCN amplified tumours to B-MYB underscores a reciprocal regulatory loop. | 9.55e-06 | 2 | 108 | 2 | 21304178 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 33280239 | ||
| Pubmed | 1.02e-05 | 560 | 108 | 10 | 35241646 | ||
| Pubmed | 1.16e-05 | 340 | 108 | 8 | 29478914 | ||
| Pubmed | 1.16e-05 | 94 | 108 | 5 | 16325481 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.43e-05 | 167 | 108 | 6 | 20362541 | |
| Pubmed | RPL26 DCAF8 UACA MRPL12 DNAJC8 ESYT1 RPS13 CLASP2 GSR SF3B6 C9orf72 RPL13A HSPA2 RPL4 EPHA7 FTSJ3 | 1.43e-05 | 1487 | 108 | 16 | 33957083 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 1.44e-05 | 583 | 108 | 10 | 29844126 | |
| Pubmed | RPL26 MRPL12 SMC1A RPS13 NKRF RPL26L1 SF3B6 TLN2 RPL13A RPL4 FTSJ3 | 1.78e-05 | 731 | 108 | 11 | 29298432 | |
| Pubmed | 1.81e-05 | 103 | 108 | 5 | 21706016 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ESYT1 SMCHD1 SMC1A RPS13 CKAP5 VPS26A PAICS NKRF ASAP1 POLR3A SF3B6 RPL13A MGA RPL4 FTSJ3 | 1.93e-05 | 1353 | 108 | 15 | 29467282 |
| Pubmed | TPM2 UACA ESYT1 SMCHD1 CLASP2 NKRF STAT3 CRYZ USO1 PHF3 SF3B6 SCAF11 C5 HCFC1 FTSJ3 | 2.25e-05 | 1371 | 108 | 15 | 36244648 | |
| Pubmed | RPL26 SMC1A RPS13 NKRF STAT3 RPL26L1 RPL13A RPL4 HCFC1 FTSJ3 | 2.28e-05 | 615 | 108 | 10 | 31048545 | |
| Pubmed | DOCK1 DOCK2 SMC1A ARHGAP35 PAICS ASAP1 ASAP2 UTP11 SF3B6 ARHGAP12 NT5C2 MGA | 2.85e-05 | 916 | 108 | 12 | 32203420 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 21779366 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 19728314 | ||
| Pubmed | Repression of Smad3 by Stat3 and c-Ski/SnoN induces gefitinib resistance in lung adenocarcinoma. | 2.86e-05 | 3 | 108 | 2 | 28115165 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 27461873 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 30015929 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 38656553 | ||
| Pubmed | Alterations in gene expression of complement components in chronic rhinosinusitis. | 2.86e-05 | 3 | 108 | 2 | 20109314 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 31819166 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 26269594 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 37497004 | ||
| Pubmed | RPL26 UACA SMC1A RPS13 CLASP2 NKRF USO1 SUMO1 PHF3 RPL13A MGA RPL4 HCFC1 FTSJ3 | 3.26e-05 | 1247 | 108 | 14 | 27684187 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.56e-05 | 398 | 108 | 8 | 35016035 | |
| Pubmed | RPL26 RPS13 CKAP5 CLASP2 ARHGAP35 MDH1 ASAP1 STRN USO1 PRKCE TLN2 CGNL1 RPL13A HSPA2 RPL4 | 3.67e-05 | 1431 | 108 | 15 | 37142655 | |
| Pubmed | A series of recombinant inbred strains between the BALB/cHeA and STS/A mouse strains. | 3.72e-05 | 21 | 108 | 3 | 4042679 | |
| Pubmed | 3.88e-05 | 655 | 108 | 10 | 35819319 | ||
| Pubmed | DOCK2 RNGTT DNAJC8 SMCHD1 SMC1A CKAP5 SIN3A PAICS KMT2C SUMO1 SF3B6 HCFC1 MYBL2 | 3.89e-05 | 1103 | 108 | 13 | 34189442 | |
| Pubmed | 3.95e-05 | 295 | 108 | 7 | 26209609 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | DOCK2 ABCA2 ACO1 ESYT1 MDH1 PAICS NT5C2 RPL13A HSPA2 RPL4 KYNU | 4.39e-05 | 807 | 108 | 11 | 30575818 |
| Pubmed | ABCA2 DCAF8 ACO1 SMC1A CKAP5 ZNF521 VPS26A MDH1 SKIL CFAP298 PAICS STAT3 TLN2 HSPA2 | 4.52e-05 | 1285 | 108 | 14 | 35914814 | |
| Pubmed | 4.95e-05 | 417 | 108 | 8 | 36537216 | ||
| Pubmed | TPM2 GALNS MRPL12 ESYT1 SMCHD1 PAICS STAT3 GSR SUMO1 RPL26L1 NT5C2 RPL13A RPL4 HCFC1 | 4.99e-05 | 1297 | 108 | 14 | 33545068 | |
| Pubmed | Modification of the base excision repair enzyme MBD4 by the small ubiquitin-like molecule SUMO1. | 5.62e-05 | 24 | 108 | 3 | 31476572 | |
| Pubmed | A Steric-inhibition model for regulation of nucleotide exchange via the Dock180 family of GEFs. | 5.71e-05 | 4 | 108 | 2 | 15723800 | |
| Pubmed | TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. | 5.71e-05 | 4 | 108 | 2 | 23353889 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 20469933 | ||
| Pubmed | Complement C3b interactions studied with surface plasmon resonance technique. | 5.71e-05 | 4 | 108 | 2 | 11367533 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 24145140 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 12149250 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 20033053 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 18398416 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 25725105 | ||
| Interaction | H1-4 interactions | MYCN RPL26 MRPL12 RPS13 FBP2 VPS26A NME8 NKRF CFB ASAP1 PHF3 RPL26L1 SCAF11 C9orf72 RPL13A RPL4 MYBL2 FTSJ3 | 7.62e-09 | 656 | 105 | 18 | int:H1-4 |
| Interaction | KCNA3 interactions | DOCK1 DNAJC8 ESYT1 SMC1A RPS13 CKAP5 MDH1 PAICS STAT3 CDC7 KMT2C ASAP2 USO1 PHF3 ARHGAP12 TLN2 RPL13A RPL4 HCFC1 | 1.08e-07 | 871 | 105 | 19 | int:KCNA3 |
| Interaction | KLF16 interactions | RPL26 MRPL12 SMCHD1 SMC1A RPS13 ZNF521 SIN3A RPL26L1 SCAF11 RPL13A MGA MYBL2 FTSJ3 | 3.27e-07 | 425 | 105 | 13 | int:KLF16 |
| Interaction | HSP90AB1 interactions | MYCN SMC1A RPS13 DNAH2 CKAP5 GBP2 MDH1 STAT3 KMT2C ASAP2 LRRIQ1 PRKCE SCAF11 CGNL1 C9orf72 HSPA2 TET3 RPL4 HCFC1 | 4.80e-07 | 960 | 105 | 19 | int:HSP90AB1 |
| Interaction | HECTD1 interactions | TPM2 RPL26 RNGTT SMCHD1 SMC1A RPS13 CKAP5 SIN3A NKRF STAT3 POLR3A CRYZ KIN PHF3 SCAF11 C9orf72 RPL13A RPL4 FTSJ3 | 6.97e-07 | 984 | 105 | 19 | int:HECTD1 |
| Interaction | PAGE4 interactions | 8.26e-07 | 253 | 105 | 10 | int:PAGE4 | |
| Interaction | RPL14 interactions | MYCN RPL26 MRPL12 RPS13 CKAP5 NKRF KIN RPL26L1 SCAF11 C9orf72 RPL13A TET3 RPL4 FTSJ3 | 1.10e-06 | 554 | 105 | 14 | int:RPL14 |
| Interaction | CNBP interactions | MYCN RPL26 SMCHD1 RPS13 PAICS NKRF RPL26L1 RPL13A RPL4 FTSJ3 | 1.81e-06 | 276 | 105 | 10 | int:CNBP |
| Interaction | YAP1 interactions | TPM2 UACA DNAJC8 SMCHD1 RPS13 CKAP5 SAV1 SIN3A ARHGAP35 PAICS NKRF KMT2C SUMO1 PHF3 RPL13A MGA HSPA2 RPL4 HCFC1 | 3.39e-06 | 1095 | 105 | 19 | int:YAP1 |
| Interaction | CEBPB interactions | DOCK2 RPL26 DCAF8 ACADM MRPL12 DNAJC8 SMCHD1 SMC1A RPS13 SIN3A MDH1 SKIL PAICS STAT3 POLR3A USO1 SUMO1 SF3B6 C5 RPL13A RPL4 HCFC1 | 4.20e-06 | 1443 | 105 | 22 | int:CEBPB |
| Interaction | EFTUD2 interactions | MYCN RPL26 MRPL12 SMCHD1 SMC1A RPS13 CKAP5 CLASP2 SIN3A ARHGAP35 MDH1 PAICS STAT3 GSR KIN SF3B6 NT5C2 SCAF11 C9orf72 RPL13A RPL4 FTSJ3 | 4.49e-06 | 1449 | 105 | 22 | int:EFTUD2 |
| Interaction | H1-5 interactions | MYCN RPL26 RPS13 POLR3A ADGB ASAP2 PHF3 RPL26L1 DNAH17 RPL4 MYBL2 FTSJ3 | 5.30e-06 | 463 | 105 | 12 | int:H1-5 |
| Interaction | NFX1 interactions | MYCN RPL26 MRPL12 RPS13 CKAP5 SIN3A NKRF UTP11 SF3B6 RPL13A RPL4 FTSJ3 | 5.66e-06 | 466 | 105 | 12 | int:NFX1 |
| Interaction | RPL37A interactions | MYCN RPL26 RNGTT MRPL12 RPS13 NKRF RPL26L1 C9orf72 RPL13A RPL4 FTSJ3 | 6.21e-06 | 391 | 105 | 11 | int:RPL37A |
| Interaction | RPL11 interactions | MYCN RPL26 MRPL12 SMC1A RPS13 SIN3A NKRF STAT3 RPL26L1 NT5C2 C9orf72 RPL13A RPL4 FTSJ3 | 7.27e-06 | 652 | 105 | 14 | int:RPL11 |
| Interaction | CHD3 interactions | RPL26 SMC1A RPS13 FBP2 SIN3A SKIL PAICS NKRF SUMO1 SF3B6 SCAF11 RPL13A RPL4 MYBL2 FTSJ3 | 8.74e-06 | 757 | 105 | 15 | int:CHD3 |
| Interaction | ADARB1 interactions | MYCN RPL26 MRPL12 SMC1A RPS13 SIN3A NKRF RPL26L1 RPL13A RPL4 HCFC1 FTSJ3 | 9.20e-06 | 489 | 105 | 12 | int:ADARB1 |
| Interaction | AURKB interactions | TPM2 MYCN RPL26 ACADM SMCHD1 SMC1A RPS13 SIN3A POLR3A CBLN4 RPL26L1 C9orf72 RPL13A RPL4 FTSJ3 | 9.30e-06 | 761 | 105 | 15 | int:AURKB |
| Interaction | RPL4 interactions | MYCN RPL26 DNAJC8 RPS13 GBP2 VPS26A NKRF CRYZ KIN RPL26L1 SF3B6 C9orf72 RPL13A RPL4 FTSJ3 | 9.75e-06 | 764 | 105 | 15 | int:RPL4 |
| Interaction | RPL7A interactions | MYCN RPL26 ACADM MRPL12 DNAJC8 RPS13 NKRF KIN CFAP77 RPL26L1 C9orf72 RPL13A RPL4 FTSJ3 | 1.15e-05 | 679 | 105 | 14 | int:RPL7A |
| Interaction | SRSF6 interactions | MYCN RPL26 DNAJC8 SMC1A RPS13 NKRF RPL26L1 SCAF11 C9orf72 RPL13A RPL4 FTSJ3 | 1.22e-05 | 503 | 105 | 12 | int:SRSF6 |
| Interaction | RBM19 interactions | 2.06e-05 | 221 | 105 | 8 | int:RBM19 | |
| Interaction | KLF15 interactions | 2.10e-05 | 290 | 105 | 9 | int:KLF15 | |
| Interaction | MRPL2 interactions | 2.27e-05 | 224 | 105 | 8 | int:MRPL2 | |
| Interaction | MYCN interactions | TPM2 MYCN RPL26 RNGTT MRPL12 DNAJC8 SMCHD1 RPS13 NKRF CBLN4 PHF3 UTP11 RPL26L1 SF3B6 SCAF11 RPL13A HSPA2 RPL4 HCFC1 FTSJ3 | 2.41e-05 | 1373 | 105 | 20 | int:MYCN |
| Interaction | ZNF22 interactions | 2.93e-05 | 114 | 105 | 6 | int:ZNF22 | |
| Interaction | MKI67 interactions | MYCN RNGTT SMC1A DNAH2 NKRF SUMO1 RPL26L1 SCAF11 RPL13A MGA RPL4 HCFC1 FTSJ3 | 3.22e-05 | 648 | 105 | 13 | int:MKI67 |
| Interaction | MEPCE interactions | DOCK1 MYCN RPL26 ACADM UACA MRPL12 DNAJC8 RPS13 CKAP5 NKRF RPL26L1 RPL13A HSPA2 RPL4 FTSJ3 | 3.82e-05 | 859 | 105 | 15 | int:MEPCE |
| Interaction | DGCR8 interactions | 3.94e-05 | 242 | 105 | 8 | int:DGCR8 | |
| Interaction | RPS28 interactions | 4.11e-05 | 316 | 105 | 9 | int:RPS28 | |
| Interaction | SLX4 interactions | SMCHD1 SMC1A NKRF GSR CDC7 KIN SUMO1 ZNF518B MGA RPL4 HCFC1 MYBL2 | 4.31e-05 | 572 | 105 | 12 | int:SLX4 |
| Interaction | BAP1 interactions | RPL26 DCAF8 MRPL12 SMC1A RPS13 CKAP5 CLASP2 MDH1 PAICS GSR KMT2C LRRIQ1 USO1 RPL26L1 RPL13A HSPA2 RPL4 HCFC1 FTSJ3 | 4.39e-05 | 1314 | 105 | 19 | int:BAP1 |
| Interaction | PARP1 interactions | MYCN DNAJC8 SMCHD1 SMC1A SIN3A PAICS NKRF ASAP2 KIN USO1 SUMO1 PHF3 SCAF11 CGNL1 C9orf72 MGA HSPA2 MYBL2 FTSJ3 | 4.48e-05 | 1316 | 105 | 19 | int:PARP1 |
| Interaction | NAA40 interactions | RPL26 MRPL12 ESYT1 SMCHD1 CKAP5 SIN3A ARHGAP35 NKRF STAT3 GSR SUMO1 CGNL1 RPL13A RPL4 HCFC1 FTSJ3 | 4.51e-05 | 978 | 105 | 16 | int:NAA40 |
| Interaction | LHX2 interactions | 4.88e-05 | 183 | 105 | 7 | int:LHX2 | |
| Interaction | POLR1G interactions | MYCN RNGTT DNAJC8 SMCHD1 SMC1A NKRF POLR3A PHF3 MGA RPL4 FTSJ3 | 4.90e-05 | 489 | 105 | 11 | int:POLR1G |
| Interaction | RPL35A interactions | MYCN DNAJC8 SMCHD1 RPS13 CKAP5 PHF3 RPL26L1 C9orf72 RPL13A RPL4 | 5.08e-05 | 405 | 105 | 10 | int:RPL35A |
| Interaction | RIT1 interactions | RPL26 GLRX5 RNGTT MRPL12 DNAJC8 SMC1A RPS13 CKAP5 VPS26A CFAP298 PAICS POLR3A USO1 UTP11 RPL4 HCFC1 MYBL2 FTSJ3 | 6.16e-05 | 1230 | 105 | 18 | int:RIT1 |
| Interaction | H1-1 interactions | RPL26 RPS13 NKRF CFB ADGB ASAP2 RPL26L1 PRKCE C9orf72 RPL4 FTSJ3 | 6.78e-05 | 507 | 105 | 11 | int:H1-1 |
| Interaction | SAR1B interactions | 7.06e-05 | 339 | 105 | 9 | int:SAR1B | |
| Interaction | DOT1L interactions | MYCN RPL26 MRPL12 SMC1A RPS13 CKAP5 PAICS NKRF PHF3 RPL26L1 SF3B6 SCAF11 RPL13A FTSJ3 | 7.61e-05 | 807 | 105 | 14 | int:DOT1L |
| Interaction | MEN1 interactions | RPL26 MRPL12 SMCHD1 SMC1A RPS13 SIN3A PAICS NKRF KMT2C RPL26L1 SF3B6 SCAF11 RPL13A RPL4 HCFC1 FTSJ3 | 8.22e-05 | 1029 | 105 | 16 | int:MEN1 |
| Interaction | RPL26L1 interactions | MYCN RPL26 MRPL12 RPS13 CKAP5 RPL26L1 C9orf72 RPL13A RPL4 FTSJ3 | 8.52e-05 | 431 | 105 | 10 | int:RPL26L1 |
| Interaction | MXD1 interactions | 8.80e-05 | 45 | 105 | 4 | int:MXD1 | |
| Interaction | SRPK2 interactions | MYCN SDK2 DNAJC8 SMCHD1 CLASP2 NKRF CBLN4 RPL26L1 ARHGAP12 SCAF11 RPL13A RPL4 FTSJ3 | 9.02e-05 | 717 | 105 | 13 | int:SRPK2 |
| Interaction | PDLIM5 interactions | 9.18e-05 | 273 | 105 | 8 | int:PDLIM5 | |
| Interaction | PSIP1 interactions | 9.97e-05 | 205 | 105 | 7 | int:PSIP1 | |
| Interaction | PODN interactions | 1.06e-04 | 18 | 105 | 3 | int:PODN | |
| Interaction | RPL6 interactions | MYCN RPL26 DNAJC8 ESYT1 RPS13 KIN RPL26L1 SCAF11 C9orf72 RPL13A RPL4 FTSJ3 | 1.20e-04 | 637 | 105 | 12 | int:RPL6 |
| Interaction | MOB3C interactions | 1.21e-04 | 364 | 105 | 9 | int:MOB3C | |
| Interaction | RPL34 interactions | 1.24e-04 | 285 | 105 | 8 | int:RPL34 | |
| Interaction | SOX2 interactions | RPL26 RNGTT MRPL12 SMCHD1 SMC1A RPS13 CKAP5 SIN3A MDH1 NKRF CFB KMT2C SUMO1 C5 RPL13A RPL4 MYBL2 EPHA7 FTSJ3 | 1.26e-04 | 1422 | 105 | 19 | int:SOX2 |
| Interaction | RPL39 interactions | 1.30e-04 | 149 | 105 | 6 | int:RPL39 | |
| Interaction | SNW1 interactions | DOCK1 DOCK2 MYCN SMCHD1 SMC1A CKAP5 SIN3A SKIL USO1 SF3B6 C9orf72 HSPA2 FTSJ3 | 1.36e-04 | 747 | 105 | 13 | int:SNW1 |
| Interaction | H3-3A interactions | MYCN SMCHD1 SMC1A CKAP5 SIN3A VPS26A KMT2C PHF3 SCAF11 C9orf72 MGA HCFC1 MYBL2 | 1.39e-04 | 749 | 105 | 13 | int:H3-3A |
| Interaction | BMS1 interactions | 1.46e-04 | 218 | 105 | 7 | int:BMS1 | |
| Interaction | RRAD interactions | 1.47e-04 | 20 | 105 | 3 | int:RRAD | |
| Interaction | EED interactions | MYCN RPL26 DNAJC8 SMCHD1 SMC1A RPS13 CKAP5 SIN3A NKRF STAT3 USO1 SF3B6 CGNL1 RPL13A MGA RPL4 HCFC1 MYBL2 FTSJ3 | 1.55e-04 | 1445 | 105 | 19 | int:EED |
| Interaction | DNAJB6 interactions | 1.64e-04 | 379 | 105 | 9 | int:DNAJB6 | |
| Interaction | SNRNP70 interactions | MYCN RPL26 RPS13 CLASP2 ARHGAP35 SKIL CFAP298 NKRF KIN RPL26L1 SCAF11 C9orf72 RPL13A RPL4 FTSJ3 | 1.74e-04 | 984 | 105 | 15 | int:SNRNP70 |
| Interaction | ZNF668 interactions | 1.82e-04 | 226 | 105 | 7 | int:ZNF668 | |
| Interaction | RPL30 interactions | MYCN RPL26 DNAJC8 RPS13 NKRF RPL26L1 C9orf72 RPL13A RPL4 FTSJ3 | 1.85e-04 | 474 | 105 | 10 | int:RPL30 |
| Interaction | SRSF5 interactions | MYCN RPL26 RPS13 NKRF RPL26L1 SF3B6 SCAF11 RPL13A RPL4 FTSJ3 | 1.85e-04 | 474 | 105 | 10 | int:SRSF5 |
| Interaction | RAN interactions | MYCN RPL26 RNGTT DCAF8 SIN3A ASAP2 SUMO1 SF3B6 C9orf72 HCFC1 | 1.88e-04 | 475 | 105 | 10 | int:RAN |
| Interaction | DRG1 interactions | 1.96e-04 | 388 | 105 | 9 | int:DRG1 | |
| Interaction | RSL1D1 interactions | MYCN RPL26 RPS13 PHF3 UTP11 RPL26L1 C9orf72 RPL13A RPL4 FTSJ3 | 2.01e-04 | 479 | 105 | 10 | int:RSL1D1 |
| Interaction | EMC9 interactions | 2.12e-04 | 163 | 105 | 6 | int:EMC9 | |
| Interaction | RPL36AL interactions | 2.15e-04 | 309 | 105 | 8 | int:RPL36AL | |
| Interaction | DCPS interactions | 2.19e-04 | 394 | 105 | 9 | int:DCPS | |
| Interaction | MKRN1 interactions | 2.27e-04 | 165 | 105 | 6 | int:MKRN1 | |
| Interaction | CDK9 interactions | TPM2 MRPL12 RPS13 CKAP5 STAT3 CDC7 RPL26L1 C9orf72 HSPA2 RPL4 MYBL2 FTSJ3 | 2.35e-04 | 685 | 105 | 12 | int:CDK9 |
| Interaction | ELMO2 interactions | 2.38e-04 | 58 | 105 | 4 | int:ELMO2 | |
| Interaction | H3C1 interactions | MRPL12 DNAJC8 ESYT1 SMCHD1 SMC1A DNAH2 SIN3A KMT2C SUMO1 PHF3 C9orf72 RPL13A MGA FTSJ3 | 2.40e-04 | 901 | 105 | 14 | int:H3C1 |
| Interaction | BRCA1 interactions | MYCN SDK2 RNGTT ACO1 SMCHD1 SMC1A RPS13 CKAP5 MDH1 PAICS NKRF STAT3 STRN USO1 SUMO1 RPL4 HCFC1 | 2.41e-04 | 1249 | 105 | 17 | int:BRCA1 |
| Interaction | BBX interactions | 2.54e-04 | 108 | 105 | 5 | int:BBX | |
| Interaction | RPL12 interactions | 2.54e-04 | 402 | 105 | 9 | int:RPL12 | |
| Interaction | BAG1 interactions | RPL26 DNAJC8 RPS13 SAV1 MDH1 CFAP298 PAICS RPL13A HSPA2 RPL4 | 2.58e-04 | 494 | 105 | 10 | int:BAG1 |
| Interaction | RPL13A interactions | MYCN RPL26 RPS13 NKRF RYR2 RPL26L1 C9orf72 RPL13A TET3 RPL4 FTSJ3 | 2.59e-04 | 591 | 105 | 11 | int:RPL13A |
| Interaction | BUD13 interactions | 2.77e-04 | 110 | 105 | 5 | int:BUD13 | |
| Interaction | RACK1 interactions | MYCN RPL26 RPS13 NKRF STAT3 CDC7 RPL26L1 PRKCE C9orf72 RPL13A RPL4 FTSJ3 | 3.01e-04 | 704 | 105 | 12 | int:RACK1 |
| Interaction | OAF interactions | 3.08e-04 | 62 | 105 | 4 | int:OAF | |
| Interaction | NHSL3 interactions | 3.13e-04 | 113 | 105 | 5 | int:NHSL3 | |
| Interaction | RPL18 interactions | MYCN RPL26 MRPL12 RPS13 KIN RPL26L1 C9orf72 RPL13A RPL4 FTSJ3 | 3.42e-04 | 512 | 105 | 10 | int:RPL18 |
| Interaction | CTPS1 interactions | 3.53e-04 | 252 | 105 | 7 | int:CTPS1 | |
| Interaction | PRPS2 interactions | 3.62e-04 | 253 | 105 | 7 | int:PRPS2 | |
| Interaction | FTSJ3 interactions | 3.63e-04 | 422 | 105 | 9 | int:FTSJ3 | |
| Interaction | ZNF677 interactions | 3.67e-04 | 27 | 105 | 3 | int:ZNF677 | |
| Interaction | CCDC140 interactions | 3.68e-04 | 117 | 105 | 5 | int:CCDC140 | |
| Interaction | LAP3 interactions | 3.68e-04 | 117 | 105 | 5 | int:LAP3 | |
| Interaction | ABT1 interactions | 3.69e-04 | 423 | 105 | 9 | int:ABT1 | |
| Interaction | TUT7 interactions | 3.83e-04 | 118 | 105 | 5 | int:TUT7 | |
| Interaction | NMI interactions | 3.83e-04 | 118 | 105 | 5 | int:NMI | |
| Interaction | RPS16 interactions | MYCN RPL26 ESYT1 RPS13 CKAP5 NKRF UTP11 RPL26L1 C9orf72 RPL13A RPL4 FTSJ3 | 3.88e-04 | 724 | 105 | 12 | int:RPS16 |
| Interaction | ZNF512 interactions | 3.89e-04 | 256 | 105 | 7 | int:ZNF512 | |
| Interaction | SURF6 interactions | 3.89e-04 | 426 | 105 | 9 | int:SURF6 | |
| Interaction | C9orf78 interactions | MYCN ACADM ESYT1 SMC1A CKAP5 SIN3A STAT3 CEP120 USO1 SUMO1 HCFC1 | 3.89e-04 | 620 | 105 | 11 | int:C9orf78 |
| Interaction | MAGEB10 interactions | 3.91e-04 | 66 | 105 | 4 | int:MAGEB10 | |
| Interaction | SRP9 interactions | 3.95e-04 | 427 | 105 | 9 | int:SRP9 | |
| Interaction | FGFBP1 interactions | 3.98e-04 | 257 | 105 | 7 | int:FGFBP1 | |
| Interaction | PIH1D1 interactions | RPL26 SMC1A RPS13 MDH1 PAICS STAT3 POLR3A GSR USO1 RPL13A RPL4 HCFC1 | 4.23e-04 | 731 | 105 | 12 | int:PIH1D1 |
| GeneFamily | L ribosomal proteins | 5.29e-05 | 51 | 73 | 4 | 729 | |
| GeneFamily | ATP binding cassette subfamily A | 1.42e-03 | 14 | 73 | 2 | 805 | |
| GeneFamily | Dyneins, axonemal | 2.10e-03 | 17 | 73 | 2 | 536 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 2.10e-03 | 17 | 73 | 2 | 1291 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | DOCK2 RNGTT ACADM SMCHD1 SMC1A ARHGAP35 PAICS NKRF GSR CDC7 STRN SUMO1 PHF3 NT5C2 SCAF11 RPL13A RPL4 KYNU MYBL2 | 3.90e-06 | 1394 | 108 | 19 | M9585 |
| Coexpression | ZHANG_UTERUS_C8_NK_CELL | 6.35e-06 | 168 | 108 | 7 | MM16614 | |
| Coexpression | DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS | ANKRD66 DNAH2 SAXO2 DNAAF11 ADGB LRRIQ1 CFAP77 CFAP74 CFAP57 | 6.77e-06 | 317 | 108 | 9 | M40298 |
| Coexpression | BENPORATH_NANOG_TARGETS | ACADM DNAJC8 RPS13 SAV1 ZNF521 MDH1 GPR108 SKIL CFAP298 STAT3 CDC7 STRN CRYZ SUMO1 NT5C2 | 1.31e-05 | 988 | 108 | 15 | M6616 |
| Coexpression | GSE42724_NAIVE_VS_B1_BCELL_DN | 1.91e-05 | 199 | 108 | 7 | M9796 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 1.97e-05 | 200 | 108 | 7 | M6045 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DOCK2 RPL26 ESYT1 SMCHD1 RPS13 GBP2 SIN3A VPS26A ARHGAP35 ATP8B2 STAT3 ASAP1 KMT2C CD2 PHF3 SCAF11 RPL13A RPL4 | 3.71e-05 | 1492 | 108 | 18 | M40023 |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | ANKRD66 DNAH2 SAXO2 DNAAF11 ADGB LRRIQ1 CFAP77 CFAP74 CFAP57 | 5.69e-10 | 179 | 108 | 9 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-10 | 184 | 108 | 9 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-10 | 184 | 108 | 9 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-10 | 184 | 108 | 9 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ANKRD66 DNAH2 SAXO2 DNAAF11 ADGB LRRIQ1 CFAP77 CFAP74 CFAP57 | 7.99e-10 | 186 | 108 | 9 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ANKRD66 DNAH2 SAXO2 DNAAF11 ADGB LRRIQ1 CFAP77 CFAP74 CFAP57 | 1.16e-09 | 194 | 108 | 9 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.53e-08 | 182 | 108 | 8 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Ciliated_cells-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.53e-08 | 182 | 108 | 8 | e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.81e-08 | 186 | 108 | 8 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.81e-08 | 186 | 108 | 8 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.89e-08 | 187 | 108 | 8 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.97e-08 | 188 | 108 | 8 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | Epithelial_cells-Ciliated_cells-A|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.14e-08 | 190 | 108 | 8 | 549d813a8f23b175875e53347928941f143e236c | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 2.14e-08 | 190 | 108 | 8 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.23e-08 | 191 | 108 | 8 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.23e-08 | 191 | 108 | 8 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.23e-08 | 191 | 108 | 8 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.23e-08 | 191 | 108 | 8 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.23e-08 | 191 | 108 | 8 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.23e-08 | 191 | 108 | 8 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.23e-08 | 191 | 108 | 8 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.23e-08 | 191 | 108 | 8 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|normal_Lung / Location, Cell class and cell subclass | 2.32e-08 | 192 | 108 | 8 | 097a13121820ab4e5cd2365600efccf5ea4ce8c3 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.52e-08 | 194 | 108 | 8 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 2.52e-08 | 194 | 108 | 8 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.62e-08 | 195 | 108 | 8 | d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.62e-08 | 195 | 108 | 8 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.62e-08 | 195 | 108 | 8 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.62e-08 | 195 | 108 | 8 | e7f069f557a59ee7b502ff82ad4c9f47fa619ba8 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.73e-08 | 196 | 108 | 8 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.73e-08 | 196 | 108 | 8 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.73e-08 | 196 | 108 | 8 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.73e-08 | 196 | 108 | 8 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.73e-08 | 196 | 108 | 8 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.73e-08 | 196 | 108 | 8 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.73e-08 | 196 | 108 | 8 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.95e-08 | 198 | 108 | 8 | 16c54b884500066ade05a406915f9569ca8abdfc | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.95e-08 | 198 | 108 | 8 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-08 | 199 | 108 | 8 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-08 | 199 | 108 | 8 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-08 | 199 | 108 | 8 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | proximal-Epithelial-Ciliated|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-08 | 199 | 108 | 8 | 9700f06e51ddca85e482b4f9bd4a79bfcd3cfb76 | |
| ToppCell | proximal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-08 | 199 | 108 | 8 | 1188afad6fd5f01f9aeba225f611f38b237dd2c9 | |
| ToppCell | proximal-Epithelial-Ciliated-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-08 | 199 | 108 | 8 | 2e8ace105c4e2405baa06d953e52888b54e2d055 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.19e-08 | 200 | 108 | 8 | 9ae434c78e08adf95da49c85616e3ca72d1227bf | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-08 | 200 | 108 | 8 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-08 | 200 | 108 | 8 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-08 | 200 | 108 | 8 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.19e-08 | 200 | 108 | 8 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-08 | 200 | 108 | 8 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-08 | 200 | 108 | 8 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-08 | 200 | 108 | 8 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-08 | 200 | 108 | 8 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-08 | 200 | 108 | 8 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.19e-08 | 200 | 108 | 8 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.19e-08 | 200 | 108 | 8 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-08 | 200 | 108 | 8 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.19e-08 | 200 | 108 | 8 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-08 | 200 | 108 | 8 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.19e-08 | 200 | 108 | 8 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.19e-08 | 200 | 108 | 8 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.19e-08 | 200 | 108 | 8 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-07 | 169 | 108 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.79e-07 | 179 | 108 | 7 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-4|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 3.01e-07 | 181 | 108 | 7 | 51d91b923920463245e95d65c6a5197e21d34d73 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.12e-07 | 182 | 108 | 7 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.36e-07 | 184 | 108 | 7 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.48e-07 | 185 | 108 | 7 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.48e-07 | 185 | 108 | 7 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 3.48e-07 | 185 | 108 | 7 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.48e-07 | 185 | 108 | 7 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.48e-07 | 185 | 108 | 7 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.75e-07 | 187 | 108 | 7 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.75e-07 | 187 | 108 | 7 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 3.88e-07 | 188 | 108 | 7 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 3.88e-07 | 188 | 108 | 7 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.88e-07 | 188 | 108 | 7 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.88e-07 | 188 | 108 | 7 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.03e-07 | 189 | 108 | 7 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.03e-07 | 189 | 108 | 7 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.03e-07 | 189 | 108 | 7 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.03e-07 | 189 | 108 | 7 | a3cd4c2da4feb9bdcd8957f3e344d095da1367b8 | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 4.03e-07 | 189 | 108 | 7 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.03e-07 | 189 | 108 | 7 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 4.03e-07 | 189 | 108 | 7 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 4.03e-07 | 189 | 108 | 7 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.03e-07 | 189 | 108 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 4.03e-07 | 189 | 108 | 7 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.03e-07 | 189 | 108 | 7 | 93b1026bb1ba759e5704561c9a5de14a30c08894 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.17e-07 | 190 | 108 | 7 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.17e-07 | 190 | 108 | 7 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.17e-07 | 190 | 108 | 7 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.17e-07 | 190 | 108 | 7 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | 4.17e-07 | 190 | 108 | 7 | cd87731aaa7d252424f79cfce9f7931457f17bdf | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 4.17e-07 | 190 | 108 | 7 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.32e-07 | 191 | 108 | 7 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | LAM-Epithelial-AirwayEpi|LAM / Condition, Lineage and Cell class | 4.48e-07 | 192 | 108 | 7 | 7404fc65be3b7bd09447725b43fa31819004dfee | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 4.48e-07 | 192 | 108 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.64e-07 | 193 | 108 | 7 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.64e-07 | 193 | 108 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| Drug | Pentetic acid [67-43-6]; Up 200; 10.2uM; PC3; HT_HG-U133A | 4.05e-07 | 196 | 108 | 9 | 4669_UP | |
| Drug | VDPs | 4.14e-07 | 4 | 108 | 3 | CID000124292 | |
| Disease | duodenal ulcer (implicated_via_orthology) | 3.83e-05 | 3 | 106 | 2 | DOID:1724 (implicated_via_orthology) | |
| Disease | factor VIII deficiency (is_marker_for) | 7.63e-05 | 4 | 106 | 2 | DOID:12134 (is_marker_for) | |
| Disease | neutropenia (implicated_via_orthology) | 2.65e-04 | 7 | 106 | 2 | DOID:1227 (implicated_via_orthology) | |
| Disease | Primary ciliary dyskinesia | 2.95e-04 | 36 | 106 | 3 | cv:C0008780 | |
| Disease | blindness (implicated_via_orthology) | 3.53e-04 | 8 | 106 | 2 | DOID:1432 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 4.73e-04 | 100 | 106 | 4 | C0010606 | |
| Disease | beta thalassemia (is_marker_for) | 6.88e-04 | 11 | 106 | 2 | DOID:12241 (is_marker_for) | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 8.24e-04 | 12 | 106 | 2 | C0023485 | |
| Disease | pulse pressure measurement | FAT3 CKAP5 OMD CCDC141 CFB STAT3 ASAP2 CEP120 ARHGAP12 NT5C2 PRKCE TLN2 HCFC1 | 1.46e-03 | 1392 | 106 | 13 | EFO_0005763 |
| Disease | T-Cell Lymphoma | 1.48e-03 | 16 | 106 | 2 | C0079772 | |
| Disease | cathepsin L1 measurement | 1.48e-03 | 16 | 106 | 2 | EFO_0010619 | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 1.60e-03 | 64 | 106 | 3 | DOID:224 (implicated_via_orthology) | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 1.67e-03 | 65 | 106 | 3 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | squamous cell carcinoma (is_implicated_in) | 1.88e-03 | 18 | 106 | 2 | DOID:1749 (is_implicated_in) | |
| Disease | atherosclerosis (biomarker_via_orthology) | 2.33e-03 | 20 | 106 | 2 | DOID:1936 (biomarker_via_orthology) | |
| Disease | Idiopathic Pulmonary Fibrosis | 2.57e-03 | 21 | 106 | 2 | C1800706 | |
| Disease | leptin measurement | 3.14e-03 | 81 | 106 | 3 | EFO_0005000 | |
| Disease | low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram | 3.35e-03 | 24 | 106 | 2 | EFO_0004611, EFO_0006329, EFO_0007871 | |
| Disease | Alveolitis, Fibrosing | 3.36e-03 | 83 | 106 | 3 | C4721507 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVLKKYGKDVGLHIK | 776 | Q13523 | |
| VQTGRDEEKLKYIKK | 321 | P21399 | |
| IDVEVKKYFCKAGVK | 221 | Q9BSJ8 | |
| LEKKQKVVLGKLYET | 241 | Q6ZQR2 | |
| KGSLKEKTVENLEKY | 211 | P49902 | |
| KKEQEVYVKKKAAQG | 1196 | Q8N7X0 | |
| KVSIYDTKGKNVLEK | 106 | P06729 | |
| GVEVLKFSQVKEVKK | 286 | P00390 | |
| KKAVLETQKIKKEYT | 31 | P0DMQ9 | |
| VAAGDYSLVKKILKK | 16 | B4E2M5 | |
| KVFGILEKAKEKYGV | 1661 | Q99758 | |
| GIKTKAEKKGDEYII | 171 | P11310 | |
| VVELVKKYKKAVTLA | 816 | P98198 | |
| KVRYVTLKEKIHKGI | 661 | Q6ZP01 | |
| IDKIKKYVGEKGIDI | 206 | Q08257 | |
| AKRNIKKKGILEEYE | 126 | O75916 | |
| KKAIVKEVIDKYTAV | 301 | O60870 | |
| EEKKLTRKEVYIKNG | 636 | P00751 | |
| VVYTEKDNKKSKLVI | 206 | P51610 | |
| QLYSDIIPEEKGKKK | 3591 | Q8NEZ4 | |
| IKVTKELKQYDNKII | 501 | O60942 | |
| KQKYSHVILGDKVTK | 926 | Q8IWI9 | |
| LISKYGEKEAVKVVL | 61 | Q86W26 | |
| VQYKAVKETKVKELK | 501 | Q9NPH3 | |
| YVGKKQLVEIEKVVL | 166 | P00739 | |
| ELKGKDEVYAVKVLK | 426 | Q02156 | |
| KKKVVKEGELHRTDY | 1116 | Q96MR6 | |
| YLLKVNEIKIKKGVD | 201 | O43150 | |
| KFKDKKEVAIVVLGN | 106 | Q9NYS0 | |
| KDAIITAKEKRGKYV | 101 | O00757 | |
| LDKYAKKSVKVIVVG | 116 | P40925 | |
| KPKVQVEYKGETKTF | 101 | P54652 | |
| KKEETYNDLIKQIGK | 296 | O95279 | |
| KLVVTKEKEKKVGLY | 321 | Q5TAQ9 | |
| KGIQAKEVLKKYLES | 451 | P32456 | |
| DVISVYSDIKGKCKK | 146 | Q8TEA1 | |
| DKVEGYKKTKEAVLL | 156 | P36578 | |
| AVAIKTLKVGYTEKQ | 661 | Q15375 | |
| QKYGPIIKEQIESKK | 301 | Q96JM4 | |
| KIVIKQGERYILVKK | 31 | Q8IWW6 | |
| VQTFKGLKIKYEKER | 636 | Q6ZMV5 | |
| ELLKKAGYVSKIVGK | 126 | P34059 | |
| DYVGKNEKTKIIAKI | 206 | P57076 | |
| DYADLVKALKKVVGK | 316 | Q14008 | |
| DALVKKDKVVVFLKG | 46 | Q86SX6 | |
| IQSFRVEYKKLKKVG | 636 | Q9BWV1 | |
| GQKYIEKIVTKHKEV | 1086 | Q6ZP82 | |
| KKKVTAKIDYGNRIL | 146 | Q14185 | |
| FKQLKEKVEKEYGVR | 1601 | Q14185 | |
| LKELKQKVTSKIDYG | 141 | Q92608 | |
| IKKGKYIKIGDKEVE | 3506 | Q9UFH2 | |
| KAKETLKKYEGEIRQ | 861 | Q0VF96 | |
| KLAGVKKDIEKLYEA | 36 | O00311 | |
| KVAEYTILEGKLQKT | 701 | Q8N960 | |
| KQYVKSLSRVLKVKG | 171 | Q5JPI9 | |
| KKIEEIAAKYKHSVV | 681 | P01031 | |
| NTVKKEVYKLEVTNK | 436 | Q8TDW7 | |
| KEDKVYLKLEKGNLV | 171 | Q9NTU7 | |
| KIENLTKVYKSRKIG | 2051 | Q9BZC7 | |
| KSKVYAENGLLEKIK | 6 | Q9NY37 | |
| YLIKVNEIKTKKGVD | 221 | Q9ULH1 | |
| IGKIENVSKLKKLEY | 56 | Q86X45 | |
| GKEYVEHTVKERKKQ | 126 | O75937 | |
| KDNISDKVLKKIGAY | 3161 | Q9P225 | |
| GYVKVQVKKQLRETK | 96 | Q99590 | |
| LIIRGQSKKYAKKTD | 1951 | Q58EX2 | |
| SLVEKVTYLKKKQAE | 2031 | Q92736 | |
| DFDIGKVYKKKITLV | 526 | Q9C0B2 | |
| TLIKYIEDDTQKGKK | 411 | Q96LT7 | |
| KIKSQKIDYGVFAKL | 126 | Q99983 | |
| RQVGKEKGKYKEELI | 126 | Q9UNX3 | |
| KVKVKKETVNSPAIY | 231 | Q9Y3A2 | |
| LVKELEGVITKAIYK | 616 | O60763 | |
| QGVITKLKEQYKKER | 326 | O43815 | |
| GKIYKAGQLVKTIKT | 606 | A6NHR9 | |
| VNQKYLGTPEEKKLK | 331 | P12757 | |
| KKTVKYEAAGEAVKT | 496 | O15226 | |
| DQKVIELVKKYGTKQ | 91 | P10244 | |
| IKYVLSDKEKKVFGI | 356 | Q9NPR9 | |
| VSEKIKKTRDKYGIN | 976 | O14802 | |
| LGKEKRHVTYVVAKK | 791 | Q8IY81 | |
| QTGIQKEDKYKIKQI | 801 | Q96ST3 | |
| KKEGEYIKLKVIGQD | 16 | P63165 | |
| IYGKHQKQIIDKAKE | 476 | Q9NRY4 | |
| DKVKLIKEIKNYIQG | 141 | P52815 | |
| KEFKKIISKYNVLQG | 506 | Q8TBZ0 | |
| KVKVAILKYIETLAK | 791 | O75122 | |
| VLNIGKKLYEGKTKE | 6 | P22234 | |
| VSKPAEVQGKYVKKE | 11 | Q9H4B6 | |
| KIINTGEKSVKYKER | 256 | Q8TB69 | |
| KIVKEAGFDLTQVKK | 471 | Q8N427 | |
| KAAKVVILKKATEYV | 416 | P04198 | |
| EKKIDKYTEVLKTHG | 186 | P40429 | |
| IKKLEELQQKVSYKG | 281 | P40763 | |
| RQVGKEKGKYKEETI | 126 | P61254 | |
| DDVKEQIYKLAKKGL | 31 | P62277 | |
| KEEQLKLLKEKYGIN | 106 | Q9Y3B4 | |
| SAIVKKKAELIKGNY | 916 | Q96K83 | |
| TKYIDDTVKHKVKIL | 816 | Q92576 | |
| TQKKYQIAVTKVLGK | 526 | Q14683 | |
| KGKAIRIEKVIYTGK | 866 | O43151 | |
| QVKKGKLDTVPTYKD | 71 | Q658L1 | |
| SQKYTEVKNVKEKLV | 1076 | Q9BZF9 | |
| NKSKYHLKDVIVGKI | 181 | O75436 | |
| AGYIDIILKKKQSKD | 396 | Q9Y4G6 | |
| KLKQGKSVKVPIYDF | 171 | Q9NWZ5 | |
| LQKKLKGTEDEVEKY | 46 | P07951 | |
| KGVSKIKIYNIKSAI | 366 | Q6NT04 | |
| KVINKYKGNVLKVVL | 961 | Q9C0D4 | |
| YGKDKAATKKPVVNI | 376 | Q16719 |